Factors associated with growth disturbance at celiac disease diagnosis in children: A retrospective cohort study

BMC Gastroenterology

Kalle Kurppa¹  Katri Kaukinen³  Markku Mäki¹  Heini Huhtala²  Juha Taavela¹  Laura Kivelä¹  Samuli Nurminen¹ 

[1] Tampere Center for Child Health Research, University of Tampere and Tampere University Hospital, Tampere, Finland;School of Health Sciences, University of Tampere, Tampere, Finland;Department of Internal Medicine, Tampere University Hospital, Tampere, Finland

关键词: Growth failure;    Children;    Celiac disease;   

Others  :  1234389
DOI  :  10.1186/s12876-015-0357-4

 received in 2015-06-18, accepted in 2015-09-25,  发布年份 2015

【 摘 要 】

Background

Impaired growth is a well-known complication in celiac disease, but factors associated with it are poorly known. We investigated this issue in a large cohort of children.

Methods

530 children with biopsy-proven celiac disease were included. The participants were divided into two groups on the basis of the presence (n = 182) or absence (n = 348) of growth disturbance at diagnosis. Histological, serological and clinical characteristics were compared between children with growth failure and those with normal growth. Further, patients with growth failure as the sole clinical presentation were compared to those with poor growth and concomitant other symptoms.

Results

Children with growth failure were younger (p < 0.001) and had lower hemoglobin (p = 0.016) and higher celiac antibody (p < 0.001), alanine aminotransferase (p = 0.035) and thyroid-stimulating hormone values (p = 0.013) than those with normal growth. Significantly associated with growth failure at diagnosis were age <3 years (OR 4.3 (95 % CI 2.5-7.5) vs older age), diagnosis before the year 2000 and in 2000–09 (OR 3.1 (1.8-5.4) and OR 1.8 (1.1-2.8) vs diagnosis in 2010–2013), presence of total and subtotal villous atrophy (OR 4.2 (2.5-7.0) and OR 2.0 (1.3-3.2) vs partial atrophy), severe symptoms (OR 3.4 (1.8-6.7) vs mild symptoms) and vomiting (OR 3.1 (1.5-6.3). The presence of abdominal pain reduced the risk (OR 0.5 (0.3-0.7)), while there was no effect of gender, diarrhea, constipation, other chronic diseases and celiac disease in the family. Children evincing poor growth as the sole clinical presentation were older (p < 0.001) and had higher hemoglobin (P < 0.001) and total iron (p = 0.010) values and lower TG2ab values (p = 0.009) than those with growth disturbance and other symptoms.

Conclusions

In particular young age and severe clinical and histological presentation were associated with growth disturbance at celiac disease diagnosis. Children with only poor growth are markedly different from those with other concomitant symptoms, suggesting different pathogenic mechanisms.

【 授权许可】

   
2015 Nurminen et al.

【 参考文献 】

• [1]Myleus A, Ivarsson A, Webb C, Danielsson L, Hernell O, Högberg L, et al.: Celiac disease revealed in 3 % of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr 2009, 49:170-176.
• [2]Hernandez L, Green PH: Extraintestinal manifestations of celiac disease. Curr Gastroenterol Rep 2006, 8:383-389.
• [3]Bottaro G, Cataldo F, Rotolo N, Spina M, Corazza GR: The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases. Am J Gastroenterol 1999, 94:691-696.
• [4]Savilahti E, Kolho KL, Westerholm-Ormio M, Verkasalo M: Clinics of coeliac disease in children in the 2000s. Acta Paediatr 2010, 99:1026-1030.
• [5]Holtmeier W, Caspary W: Celiac disease. Orphanet J Rare Dis 2006, 1:3. BioMed Central Full Text
• [6]Jansson UH, Kristiansson B, Magnusson P, Larsson L, Albertsson-Wikland K, Bjarnason R: The decrease of IGF-I, IGF-binding protein-3 and bone alkaline phosphatase isoforms during gluten challenge correlates with small intestinal inflammation in children with coeliac disease. Eur J Endocrinol 2001, 144:417-423.
• [7]Street ME, Volta C, Ziveri MA, Zanacca C, Banchini G, Viani I, et al.: Changes and relationships of IGFS and IGFBPS and cytokines in coeliac disease at diagnosis and on gluten-free diet. Clin Endocrinol 2008, 68:22-28.
• [8]Ferrante E, Giavoli C, Elli L, Redaelli A, Novati E, De Bellis A, et al.: Evaluation of GH-IGF-I axis in adult patients with coeliac disease. Horm Metab Res 2010, 42:45-49.
• [9]Delvecchio M, De Bellis A, Francavilla R, Rutigliano V, Predieri B, Indrio F, et al. Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment. Am J Gastroenterol. 2010;105:691–6.
• [10]Patwari AK, Kapur G, Satyanarayana L, Anand VK, Jain A, Gangil A, et al.: Catch-up growth in children with late-diagnosed coeliac disease. Br J Nutr 2005, 94:437-442.
• [11]Weiss B, Skourikhin Y, Modan-Moses D, Broide E, Fradkin A, Bujanover Y: Is adult height of patients with celiac disease influenced by delayed diagnosis? Am J Gastroenterol 2008, 103:1770-1774.
• [12]Pärnänen A, Kaukinen K, Helakorpi S, Uutela A, Lähdeaho ML, Huhtala H, et al.: Symptom-detected and screen-detected celiac disease and adult height: a large cohort study. Eur J Gastroenterol Hepatol 2012, 24:1066-1070.
• [13]Fuchs V, Kurppa K, Huhtala H, Collin P, Mäki M, Kaukinen K: Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol 2014, 49:1304-1310.
• [14]Coeliac disease (online). Current Care Guidelines. Working group set up by the Finnish Medical Society Duodecim and the Finnish Society of Gastroenterology. Helsinki: The Finnish Medical Society Duodecim, 2010. Available online at: www.kaypahoito.fi. Accessed 20 October 2014.
• [15]Ladinser B, Rossipal E, Pittschieler K: Endomysium antibodies in coeliac disease: an improved method. Gut 1994, 35:776-778.
• [16]Taavela J, Koskinen O, Huhtala H, et al.: Validation of morphometric analyses of small-intestinal biopsy readouts in celiac disease. PLoS One 2013., 8Article ID e76163
• [17]Saari A, Sankilampi U, Hannila ML, Kiviniemi V, Kesseli K, Dunkel L: New Finnish growth references for children and adolescents aged 0 to 20 years: Length/height-for-age, weight-for-length/height, and body mass index-for-age. Ann Med 2011, 43:235-248.
• [18]Saari A, Harju S, Mäkitie O, Saha MT, Dunkel L, Sankilampi U: Systematic growth monitoring for the early detection of celiac disease in children. JAMA Pediatr 2015., 169Article ID e1525
• [19]Weizman Z, Ben-Zion YZ, Binsztok M, Maor E, Porath A: Correlation of clinical characteristics and small bowel histopathology in celiac disease. J Pediatr Gastroenterol Nutr 1997, 24:555-558.
• [20]Donaldson MR, Firth SD, Wimpee H, Leiferman KM, Zone JJ, Horsley W, et al.: Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease. Clin Gastroenterol Hepatol 2007, 5:567-573.
• [21]Jatla M, Bokhari A, Bierly P, Russo P, Verma R: Anthropometric, serologic, and laboratory correlation with villous blunting in pediatric celiac disease: diabetics are different. J Clin Gastroenterol 2009, 43:622-626.
• [22]Murray JA, Rubio-Tapia A, Van Dyke CT, Brogan DL, Knipschield MA, Lahr B, et al.: Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol 2008, 6:186-193.
• [23]Bingley PJ, Williams AJ, Norcross AJ, Unsworth DJ, Lock RJ, Ness AR, et al.: Undiagnosed celiac disease at age seven: population based prospective birth cohort study. BMJ 2004, 328:322-323.
• [24]Taavela J, Kurppa K, Collin P, Lähdeaho ML, Salmi T, Saavalainen P, et al.: Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease. Clin Gastroenterol Hepatol 2013, 11:166-171.
• [25]Agardh D, Lee HS, Kurppa K, et al.: for the TEDDY Study Group. Clinical Features of Celiac Disease: A Prospective Birth Cohort. Pediatrics 2015, 135:627-634.
• [26]Lindfors K, Kaukinen K: Contribution of celiac disease autoantibodies to the disease process. Expert Rev Clin Immunol 2012, 8:151-154.
• [27]Brar P, Kwon GY, Egbuna II, Holleran S, Ramakrishnan R, Bhagat G, et al.: Lack of correlation of degree of villous atrophy with severity of clinical presentation of coeliac disease. Dig Liver Dis 2007, 39:26-29.
• [28]Thomas HJ, Ahmad T, Rajaguru C, Barnardo M, Warren BF, Jewell DP: Contribution of histological, serological, and genetic factors to the clinical heterogeneity of adult-onset coeliac disease. Scand J Gastroenterol 2009, 44:1076-1083.
• [29]Abu Daya H, Lebwohl B, Lewis SK, Green PH: Celiac disease patients presenting with anemia have more severe disease than those presenting with diarrhea. Clin Gastroenterol Hepatol 2013, 11:1472-1477.
• [30]Umar SB, DiBaise JK: Protein-losing enteropathy: case illustrations and clinical review. Am J Gastroenterol 2010, 105:43-49.
• [31]Ludvigsson JF, Ansved P, Fälth-Magnusson K, Hammersjö JA, Johansson C, Edvardsson S, et al.: Symptoms and signs have changed in Swedish children with coeliac disease. J Pediatr Gastroenterol Nutr 2004, 38:181-186.
• [32]Catassi C, Fasano A: Celiac disease as a cause of growth retardation in childhood. Curr Opin Pediatr 2004, 16:445-449.
• [33]Sanderson IR: Growth problems in children with IBD. Nat Rev Gastroenterol Hepatol 2014, 11:601-610.
• [34]Elfström P, Montgomery SM, Kämpe O, Ekbom A, Ludvigsson JF: Risk of thyroid disease in individuals with celiac disease. J Clin Endocrinol Metab 2008, 93:3915-3921.
• [35]Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, et al.: 2013 ETA Guideline: Management of Subclinical Hypothyroidism. Eur Thyroid J 2013, 2:215-228.
• [36]Bona G, Prodam F, Monzani A: Subclinical hypothyroidism in children: natural history and when to treat. J Clin Res Pediatr Endocrinol 2013, 5(S1):23-28.
• [37]Roma E, Panayiotou J, Karantana H, Constantinidou C, Siakavellas SI, Krini M, et al.: Changing pattern in the clinical presentation of pediatric celiac disease: a 30-year study. Digestion 2009, 80:185-191.
• [38]Rashid M, Cranney A, Zarkadas M, Graham ID, Switzer C, Case S, et al.: Celiac disease: evaluation of the diagnosis and dietary compliance in Canadian children. Pediatrics 2005, 116:754-759.
• [39]Oostdijk W, Grote F, de Muinck K-SS, Wit J: Diagnostic approach in children with short stature. Horm Res 2009, 72:206-217.
• [40]Cohen LE: Idiopathic short stature: a clinical review. JAMA 2014, 311:1787-1796.